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ABSTRACT
FEEDBACK CONTROL OF FED-BATCH CULTURES
USING RAMAN SPECTROSCOPY FOR METABOLITE ESTIMATION
by
Brian Hadley
University of New Hampshire

The monitoring and control of mammalian cell culture processes are critical for the safe
and cost-effective development of biotherapeutics in drug development. Current control using
off-line sampling is infrequent and can miss important metabolic shifts which can impact product
quality and consistency. Raman spectroscopy can provide in-line monitoring of multiple
metabolites and critical process parameters to allow automation and process improvements. In
this research a generic model was developed for monitoring multiple cell lines with a platform
Chinese hamster ovary (CHO) cell process. Parameter estimation was then used for the
implementation of feedback control. Two nutrient feeds were added based on the culture needs as
measured approximately every hour for viable cell and glucose concentrations without operator
intervention. This demonstrated comparable, if not improved, control compared to historically
adjusting feeds based on daily off-line sampling.

Keywords:
Automation.

x

GS-CHO Mammalian Cell Culture, Raman Spectroscopy, Fed-batch

1. LITERATURE REVIEW
Overview of Lonza
Lonza Biologics is a global leader in the manufacturing of biopharmaceutical drugs
(Lonza, 2007). Lonza has a focus on the consistent manufacturing of recombinant proteins using
mammalian cell culture. Due to the complex nature of protein structure and function, process
consistency is vital to produce safe active pharmaceutical ingredients (API). Additionally, as the
market demand for monoclonal antibodies has increased, so has the scale and investment in cell
culture. Lonza helped pioneer the scale-up and cost-effective production, up to 20,000 liters,
utilizing mammalian cell culture (Varley & Birch, 1999). In order to stay competitive, Lonza
continues to invest and implement new technologies to ensure maximized yields for safe and
effective drug production for patients. In the present thesis project, the goal was to explore the
use of Raman spectroscopy as part of continuing efforts to improve the manufacturing of
therapeutic recombinant proteins, and consequently, the quality of life for all patients who rely
on these critical drugs for treatments.
History of the Monoclonal Antibody Market
One of the most prevalent and highest grossing protein therapeutics by market share is a
class of proteins called monoclonal antibodies (mAbs) (Pavlou & Reichert, 2004). Kohler &
Milstein (1975) demonstrated a method using tissue cultures from mice to produce mAbs. This
Nobel Prize-winning work eventually led to Food and Drug Administration (FDA) approval of
Orthoclone (OKT3) for human trials, which offered a novel targeted protein for preventing
kidney transplant rejection.
However, this initial mouse antibody triggered an immune response and was
subsequently removed from the market (Liu, 2014; Ecker, et al., 2015). Advancements in protein
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engineering brought about the replacement of parts of the murine monoclonal antibody with a
human sequenced section to reduce immunogenicity. This progression (Figure 1) from chimeric
to a fully human-sequenced monoclonal antibody and antibody fragments provided the safety to
investigate other drug targets (Weinberg, et al., 2005; Shepard, et al., 2017). By improving the
safety of these drugs, new treatments became available to help improve the quality of life for
patients with rheumatoid arthritis, Crohn’s disease, plaque psoriasis, multiple cancers, and
autoimmune diseases (Buss, et al., 2012; Khan, 2013). As of 2017, the market based on this
discovery has grown to greater than $98 billion annually (Grilo & Mantalaris, 2019).
Figure 1 –

The Structure of an Antibody and Progression of Humanized Monoclonal Antibodies to
Reduce Risk of Immunogenicity.

*Taken from (Shepard, et al., 2017) Fig 1. Monoclonal antibodies
A – antibody structure showing light (L) and heavy (H) chains with variable (VL, VH) and constant (CL,
CH) regions, which are connected by inter-chain disulphide bonds. Antigen binding (green symbol) occurs
at VH/VL domains, while effector functions are mediated via the Fc (CH) portion.
B – increasing the amount of human sequences in a murine antibody decreases immunogenic potential.
C – on an antibody-drug conjugate (ADC, cytotoxic drugs (orange, red stars) can be linked stochastically
to lysine (Lys) residues or on cysteine residues either through reduction of inter-chain disulphides (Cys)
or by engineering in cysteines at select conjugation sites (site-specific).

Cell Line Selection and Media Development
Therapeutic proteins, e.g., mAbs, have been produced using multiple cell lines derived
from bacterial, insect, rodent, and human cells (Palmberger, et al., 2011). These cell lines offer
2
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different advantages, based on the proteins being produced. Bacteria replicate rapidly, allowing
short scale-up and production timelines. However, post-translational modifications like
glycosylation and sialyation have not been fully demonstrated with prokaryote cells as the
complexity of eukaryotic O-linked and N-linked glycosylation is not yet fully understood.
(Larkin & Imperiali, 2011; Eichler & Koomey, 2017). With the need for post-translational
modifications to more closely resemble human proteins for improved efficacy and safety of
mAbs, mammalian cell culture quickly took over as the preferred choice of production (Jefferis,
2009b). Two cell lines that emerged as stable and able to produce proper protein characteristics
were Chinese hamster ovary (CHO) (Tijo & Puck, 1958) and mouse myeloma (NS0) cells (Potter
& Boyce, 1962). One advantage of the CHO cell line was a reduced need for lipids and
cholesterol supplementation. To date, CHO cells have been the dominant cell line due to their
robust growth and high productivity (Jefferis, 2009a; Liu, et al., 2014).
However, the transfection and selection of each cell line can be a long and intensive
process with only a few key process parameters being monitored. Cell growth and productivity
are generally prioritized over efficient metabolism. As a result, thousands of cell lines may be
evaluated from a pool to choose the ideal one for further production. The tedious process of
clone selection is summarized in Figure 2.
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Figure 2 –

Process of Clone Selection and Cell Line Scale up and Testing.

*Taken from Figure 1 (Noh, et al., 2018).
A schematic diagram of the process for mAb producing clone generation and long-term culture
for testing the production stability. Different concentrations of methionine sulfoximine (MSX)
may be used with the GS System®.

To improve the homogeneity of the cell population, selection is required after transfection
because of the variation in the pool of transfected cells (Stark & Wahl, 1984). Gene amplification
or selection with antibiotics can be used to select against poor productive cell populations
(Bebbington, 1991; Lai, et al., 2013). However amplification can lead to variation and toxicity in
the cell (Barnes, et al., 2000; Mun, et al., 2015). Moreover, the rise of antibiotic resistant bacteria
also increased regulatory scrutiny of approaches using antibiotics, which further decrease their
desirability as a selective agent.
An important adaptation of cell lines which helped to rapidly reduce development costs
was the introduction of expression systems like dihydrofolate reductase (DHFR) and glutamine
synthetase (GS) (Wurm, 2004; Birch & Racher, 2006). The GS System® developed by Lonza
Biologics can reduce cell line development by 3 months, compared to DHFR clones, thanks to
4
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requiring lower gene copy numbers to achieve a similar expression level of the target protein
(Butler, 2005). The GS System® also eliminated the need for potentially harmful selective agents,
like methotrexate (MTX) for DHFR, or antibiotics (Noh, et al., 2018). By removing glutamine
from the media supplied to cells, it was also possible to select for higher producing cells without
gene amplification (Fan, et al., 2012). Currently, over 35 products are commercially approved
using the GS expression system (Lonza, 2007).
While selecting high producing cell lines is necessary to reach certain product titers,
another critical aspect for monoclonal antibody production is the selection of the appropriate
culture medium. Further, variability in raw materials supplemented to culture media for growing
up and culture expansion of CHO cells had to be reduced, in order to reliably control amounts of
added complex proteins (Ritacco, et al., 2018). As such, a main contributor of variability is fetal
bovine serum (FBS). This animal-derived, protein-rich solution not only impacts the culture
performance and product quality, but also potentially contains harmful viruses or prions which
have led to product recalls in the past (van der Valk, et al., 2010; EMA, 2013; Kishishita, et al.,
2015). To reduce reliance on serum-containing media, solutions like Primatone RL were
introduced (Schlaeger, 1996). These solutions contained protein hydrolysates to supply necessary
amino acids, and oligopeptides, and were fortified with iron salts, lipids and other trace low
molecular weight substances to improve culture performance in the absence of serum. However,
the complexity and inconsistency of this raw material has led to process variability, as well as
potentially leading to processing challenges in downstream purification of the protein of interest.
As improvements in identifying the components of serum and hydrolysates were realized,
chemically defined (CD) media were created that reduced and ultimately removed the need for
serum in cell culture medium. (Chong, et al., 2009; Mulukutla, et al., 2017; Pereira, et al., 2018).
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Consequently, this also led to other improvements in scale-up for improved mass transfer and
reduced shear sensitivity by incorporating surfactants like poloxamers (Keen & Rapson, 1995;
Zhu, 2012). Chemically defined media have been widely accepted as essential to robust protein
production and higher productivity for mammalian cell cultures and have additionally alleviated
regulatory concerns.
Processing Fed-Batch Cultures at a Large Scale
The next improvement in cell culture technology implemented the economy of scale.
Initially, cells required attachment to flasks, requiring a large surface area, and potentially large
facility footprint in order to scale up. Adaptation of suspension variant cell lines enabled the cells
to prosper without being confined to a 2-dimensional scaffold and therefore allow larger volumes
of production in similar facility footprints. This also led to longer culture durations, so that more
protein could be produced for lower cost between batches (Chu & Robinson, 2001). However,
the scaling-up process introduced new challenges, i.e., how to ensure similar cellular metabolism
and product quality attributes as the smaller-scale process (Varley & Birch, 1999; Alvin W.
Nienow, 2006; Ahuja, et al., 2015; Alvin Nienow, 2015; Williamson, et al., 2018).
Traditional scale-up processes incorporate a batch mode, in which cells are first grown in
small flasks and then expanded to production bioreactors containing tens of thousands of liters of
culture. Inoculating cells into media at a low concentration allows fresh nutrients to promote
exponential growth and expand volumes. However, if the media is too concentrated the cells can
be hindered by osmotic pressure. Too few nutrients limit the growth potential of the culture.
Fed-batch introduces a concentrated feed of nutrients into the culture that can expand the growth
potential from several days to over two weeks. At the largest volume, a fed-batch mode can
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achieve much higher concentrations and extend the stationary phase of the cell life cycle,
resulting in increased production yields (Alldread, et al., 2014).
As a consequence of increased addition of nutrients and extended batch duration,
unwanted cellular byproducts could accumulate in cultures (Zagari, et al., 2013; Liu, et al., 2014;
Matthews, et al., 2016). Lactate has been shown to inhibit growth (Lao & Toth, 1997), while
ammonium toxicity resulted from the metabolism of glutamine (Schneider, et al., 1996). In some
cases, this could affect not only productivity but product quality. This is one area where the GS
System® has demonstrated a great benefit. By selecting for increased synthesis of the GS enzyme,
glutamine can be removed from the CD media. Also, feeding of glutamate instead of glutamine
reduced the likelihood of high levels of ammonium buildup as glutamate must first be converted
to glutamine via glutamine synthetase, before being converted to NH4.
Limiting nutrients and metabolites beyond glutamine are also critical to reduced waste
accumulation, and improve culture control and productivity (Gagnon, et al., 2011; Zhang, et al.,
2015). A balance of fixed and bolus feed additions is often required, adding complexity to the
manufacturing process and reducing the ability to adjust processes if metabolic shifts occur or
raw material variability contributes to other unknown process changes (Templeton, et al., 2013).
In order to reduce this variability across multiple cell lines and processes, advanced process
monitoring is required for feedback control to improve process robustness (Aehle, et al., 2011).
Implementation of Process Analytical Techniques (PAT) and Raman Spectroscopy
By releasing a PAT initiative to encourage investment and confidence in innovation, the
FDA acknowledged and supports that new technologies have the potential to reduce process
variability and improve product safety and efficacy (FDA, 2004). The FDA guidelines describe a
framework to encourage industry to invest and develop innovative technologies. The goals of the
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initiative were to develop methods and let science guide safety regulation and increase
understanding and process robustness in the manufacture of recombinant proteins. Historically,
changes to processes would be met with strict, and sometimes unachievable hurdles to
demonstrate comparability of new technologies to previously established ones. For instance, a
method of counting cells using an automated procedure and computer imagery could be more
precise than multiple people counting the same sample. However, differences inherent in the
improvement of methods should not discredit the potential of these new technologies.
One current aspect that could be improved in the manufacturing process is the monitoring
and supplementation of nutrients and metabolites in culture. Previously available analytical
methods required the removal and destruction of samples taken out of the bioreactor. The time
and cost required for each sample generally results in once daily sampling to adjust feed rates.
While mostly effective for eliminating nutrient depletion, this infrequent method could miss
significant shifts in metabolism and lead to poor control and oscillation in the concentrations of
desired metabolites (Mulukutla, et al., 2010). This potential source of variation in the process
could also impact product quality, and ultimately patient safety (Wiltberger, et al., 2015).
Various spectroscopic methods have been reviewed for their efficacy and use inside the
bioreactor to reduce time and contamination risks (Rowland-Jones, et al., 2017). Ultraviolet and
visible light (UV/Vis) are relatively inexpensive and widely used methods for protein
measurement in purified product streams. However, in cell culture, host cell proteins required for
cell growth and metabolism can interfere with this measurement and make it more difficult to
interpret (Leme, et al., 2014). Infrared spectroscopy has been utilized from near infrared (NIR)
(Kozma, et al., 2017) to mid-IR and Fourier transformed infrared (FTIR) (Rhiel, et al., 2002) to
measure product concentrations in fermentation
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spectroscopy is highly susceptible to the polar bonds of water molecules which can mask small
changes in metabolites of interest in cell culture media. Water is the primary cell culture media
component which can interfere with key process parameters like glucose and lactate using NIR
(Li, et al., 2018).
Another option for cell culture monitoring is Raman scattering, which is the inelastic
scattering of photons, i.e., light bounces back at a different frequency than it was transmitted.
Using a monochromatic light source, energy can be transferred to molecules in the sample and
measured based on returning to the same level as before (Raleigh scattering), a higher energy
level (Stokes) or lower energy level (Anti-Stokes) (Skoog, et al., 2017). This Stokes and AntiStokes Raman scattering occurs at very low levels, but can be measured with sensitive-charged
couple devices (CCD) to determine the molecular fingerprint based on the rotational levels
identified in the spectra (Tsigkou, et al., 2005). The intensity of the energy change determines the
concentration of components in solution which allows for quantitative analysis (Gremlich, 1999).
This also reduces the impact of water on the analysis, thereby improving specificity.
The equipment availability for dispersive Raman spectroscopy probes offers a distinct
advantage over other infrared spectroscopy methods. Short cable lengths for FTIR and NIR
require the sensitive electronics be placed near the bioreactor. This limits the ability to separate
the sensitive electrical components and camera for the sensor from the product contact window
of the sensor, which generally undergoes heat sterilization. By requiring axenic cultures for
bioprocesses this restricts sterilization to steam in place bioreactors. Autoclave sterilization
provides cost effective and flexible installation at small scale (i.e. laboratory scale) bioreactors
compared to steam in place (SIP). Raman spectroscopy can be implemented across varying
lengths of fiber optic cable and can allow probe disconnects for mobile, autoclavable 1-liter
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bioreactors. Furthermore, minimal signal loss has been demonstrated when increasing from a 5
meter to 60+ meter fiber optic cable required for implementation in a large clean room, SIP ready,
20,000L bioreactor (Zhang, et al., 2014).
In recent years, studies have reported successful monitoring of mammalian cell cultures
with dispersive Raman spectroscopy, using a 785 nm wavelength (Abu-Absi, et al., 2011;
Moretto, et al., 2011). However, Raman scattering is still extremely low compared to Raleigh
scattering of light, which requires more scans to increase signal and overcome noise from
background or equipment variations. Multiple scans at short exposures allow for improving the
signal-to-noise ratio to overcome other challenges like bubble interference when subsurface
supplemental gasses are supplied to a bioreactor by a process referred to as sparging (Short, et al.,
2005). This use of aggregating multiple scans to interpret the small changes caused by molecular
vibrations in the complex system means mathematical processing of the data is required.
Spectra Processing and Model Development
Pre-processing of the spectral data is a method of using algorithms to reduce error in the
spectra or between instruments that would otherwise cause variability in any estimation
(Lagresle, et al., 2017). Various sources of error from a “true” Raman spectrum are shown in
Figure 3. Molecular components that fluoresce can accumulate in a culture overtime and increase
the background level of intensity in the Raman spectra. Even cosmic spikes from natural
radiation can lead to errors in the readings. To reduce this interference, several techniques can be
applied, e.g., the Savitzky-Golay derivative, to reduce background and filter noise (Savitzky &
Golay, 1964). In addition, trimming the spectra to the fingerprint region and scaling with
normalization can also reduce variation between lasers or CCD baseline in different equipment
(Bocklitz, et al., 2011).
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Figure 3 –

Components of Noise and Variation that Require Processing for Mathematical Reduction
During Model Development.

*Taken from Figure 2 (Bocklitz, et al., 2011)
Spectrum composition. The measured Raman spectra are suffering from different side effects, like
fluorescence background, cosmic spikes and white noise. All contributions have to be rejected prior the
analysis.

Once the spectra have been optimized, the estimation of individual components (e.g.,
glucose and lactate) in a dynamic multi-week, multi-feed, cell culture process, at all stages and
all concentrations, requires a reference (Mehdizadeh, et al., 2015). Although peaks for glucose
and lactate in solution are well defined, parsing out specific concentrations in cell culture media
requires multivariate analysis using partial least squares (PLS) (Whelan, et al., 2012). In order to
provide adequate estimates, partial least square regression models need a representative reference
method to correlate to spectra samples to be analyzed (André, et al., 2017). Therefore, the
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accuracy of the Raman model’s estimation is limited by the reference method as well as any
errors that were incurred during sample preparation.
In order to create predictive models for multiple key process parameters from Raman
spectra, sufficient data are needed to ensure that the entire range of expected parameter
concentrations is incorporated (Xu, et al., 1997). It is also important to ensure that collinearity
between parameters is not inadvertently included. For fed-batch culture, it is common to add
nutrients including amino acids, vitamins, and trace metals based on the viable cell concentration
(VCC), as measured by trypan blue exclusion. By increasing the addition of the nutrients as the
VCC increases, it is possible to create model estimations based on an inaccurate correlation to an
unrelated component. This could lead to future predictions that are unreliable if culture
conditions or raw material composition change unexpectedly in the future. In order to prevent
these correlations, spiking studies can be designed to increase a components concentration at
multiple time points within the culture (Santos, et al., 2018; Rowland-Jones & Jaques, 2019).
Generic Model Development
A platform process can be used consisting of the same media and feeds for multiple
different cell lines. However, the cell line selection process to produce proteins biologically may
create variability in metabolism and nutrient utilization of the basal media by different cell lines.
In order to produce a robust strategy for feedback control utilizing Raman spectroscopy, a
generic model for multiple cell lines was developed to support this automation (Webster, et al.,
2018). This generic model was used for an initial study of multiple parameters including glucose,
lactate, ammonium, total cell concentration (TCC), VCC, and product concentration. Two cell
lines were used with varying concentrations of glucose in the basal medium to develop the
generic model and verified against a third independent cell line.
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Another source of variation in cell culture is the cell line itself. The cell morphology may
be different between cell lines as shown from capacitance studies (Moore, et al., 2019). Changes
in metabolic profiles between cell lines can also impact the spectral profile causing discrepancies
in the viable cell concentration estimation. This could create a problem with a generic model for
measuring cell concentration across multiple cell lines whereas a model of a metabolite like
glucose, or amino acid in the same media formulation could be more accurate as the spectral
fingerprint is unchanged by the cell line.
Summary
By monitoring cell cultures in-line this allows control of multiple parameters that may
not have been possible by manual sampling. For example, this could lead to tighter control
around a lower concentration of a specific culture media ingredient, that if breached could be a
limiting factor or lead to irreparable harm to cell growth and metabolism. Thus, in order to
implement the necessary components of control during cell cultures, the present thesis research
project carried out a three-stage approach. First, the software and automation potential for
incorporating Raman spectroscopy into a bioreactor controller was established. Next,
improvements to the generic Raman spectroscopy platform process model were made, based on
generation of new data and cultures that provided a designed approach to reduce collinearity.
Finally, control improvements and a novel platform process were incorporated to demonstrate
the control of both a glucose-feed and nutrient-feed based on real-time feedback of the bioreactor
glucose and viable cell concentrations. By providing constant feedback using Raman
spectroscopy this could result in decreased variability in the production process.
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2.RATIONALE AND THESIS GOALS
2.1.Goal 1 - Test Automation Capabilities
The manufacture of therapeutic proteins is predominantly performed using fed-batch
processes. Nutrient feeds are added to prolong typical batch cultures, and improve productivity
by maximizing viable cell concentration, and maintaining optimal concentrations of metabolites
like glucose and glutamate in cell culture. Lonza’s CHO platform processes typically adjust these
feed rates once daily based on off-line measurements of viable cell and glucose concentrations
by the Vi-CELL™ XR and Nova BioProfile® 400, respectively. The CHOK1SV GS-KO® V9
platform process has two continuously added proprietary feeds containing a complex assortment
of nutrients (i.e., amino acids, vitamins, and trace elements), and glucose.
The nutrient feed flow rate is calculated, based on the VCC at the time of sampling and
bioreactor volume. However, to obtain the VCC, a trained operator is required to remove a
sample from the bioreactor every day. This can be susceptible to sample or dilution error and
requires expensive and toxic reagents for analysis. Additionally, every sample removed from the
bioreactor carries a potential risk of contamination as well as product loss.
The glucose feed rate is determined using a complex calculation that requires the
previous day’s sample time, VCC, and glucose concentration, as well as the current sample time,
VCC, glucose, bioreactor volume, and target glucose. It also requires assumptions based on cell
growth to estimate a predicted VCC at the next sample time, usually 24 hours later. All of this
information needs to be entered into a validated spread sheet. This calculation can be prone to
both instrument and human errors. It also assumes constant metabolic activity over a 24-hour
period which may lead to poor predictions and poor control of glucose concentrations.
Deviations can be costly if control is not maintained within a defined acceptable range of the
process, as defined during clinical manufacturing of the drug substance. Variability in the glucose
14
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concentration could also lead to product quality variability or early culture decline and
productivity loss (Liu, et al., 2014).
The first step in this research was to provide a proof of concept that a generic Raman
model (Webster, et al., 2018) for glucose and VCC could enable control of two feeds in the fedbatch process using Raman spectroscopy. Hourly estimations of glucose concentration and viable
cell concentration were transferred from a Kaiser Optical Systems, Inc. (Kaiser) Raman system
through Open Platform Communication (OPC) to Bioxpert XP software, in order to control the
nutrient and glucose feed rates in real-time, without manual operator intervention.
2.2.Goal 2 – Model Generation Using a Design of Experiments (DOE) Approach
Goal 2 focused on improving the robustness of the generic Raman model to ensure that
measurement of changes in VCC are detected irrespective of similar changes in nutrient
concentrations. Because the nutrient feed is based on a linear formula including the VCC, there is
an inherent collinearity between the VCC and the amount of nutrient feed being added. This
collinearity can mask changes in VCC or confuse model development when using Raman
spectroscopy.
After pre-processing the Raman spectra, or more specifically wave numbers, PLS can
correlate the off-line analysis (Y variable, like glucose) to the Raman wave number intensities (X
variables) to explain the variance. This PLS model is represented by an algorithm to calculate the
Y variable from the selected Raman wavenumbers. However, this method is poor at extrapolating
predictions, requiring the full range of expected concentrations to be included in the calibration
model. Spiking studies have been used to break correlations between wave numbers and multiple
components. Also increasing concentrations of a single metabolite of interest provides higher
than expected concentrations within the model to eliminate the need to extrapolate. While simple
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to add glucose that is already available, it is more difficult to maintain and add concentrated
viable cells independently to a process.
In order to stretch the limits of a production process, which is already common practice
during the biological drug development, a Design of Experiments (DOE) could be used. It is a
regulatory requirement to define the acceptable limits for safe and reproducible manufacturing.
Process acceptability is dependent on process limits evaluation (PLE) studies, which are
generally performed for new customers during process transfer and/or scale up. This PLE study
will be used to define the acceptable limits of critical process parameters (CPP) including but not
limited to temperature, pH, and/or dissolved oxygen tension.
The objective of the present study was to evaluate an improved method of Raman
modeling that could allow for rapid, cost-effective predictive model development for individual
processes as well as improve the Raman model for VCC estimation used in previous feedback
control. The glucose was maintained at high, low, and center point concentrations. The formula
for adding the nutrient feed was also changed by +/- 20% based on previously studied acceptable
limits of the process. This DOE approach to Raman model development could be more robust
across different cell lines and limit collinearity between viable cells and the amino acids and
nutrients that may also be Raman active in the cell culture media, especially when the feed
addition rates are directly tied to the VCC.
2.3.Goal 3 – Improve Automation Across Three New Cell Lines
In the final study of the present thesis research project, an automated approach to
controlling bioreactors using Raman spectroscopy is demonstrated using an improved generic
model and three previously unused CHOK1SV GS-KO® CHO cell lines. Raman estimations of
glucose and VCC were used to control a glucose feed and proprietary nutrient feed, respectively.
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Improved software was also required to improve robustness in communication from a
Kaiser Raman system through open platform communication (OPC) to Lucullus® process
information management software (PIMS) from Securecell. In addition to demonstrating control
of the nutrient and glucose feed rates in real-time, without manual operator intervention, control
cultures were performed to demonstrate comparability to current daily adjustments of feed rates
based on off-line measurements and manual calculations.
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3.METHODS
3.1.Laboratory Operations and Inoculum Generation
All cultures used Lonza developed media and CHOK1SV GS-KO® or GS-CHO cell lines.
The cell lines were grown up from vials in a proprietary inoculum medium. This was prepared
from powdered medium components and supplements commercially available from Lonza,
Verviers. Deionized (DI) water filtered by a Milli-Q system was also used in the Lonza
Portsmouth, NH Research and Development Laboratory. The Milli-Q ultrapure water (Type 1)
produces water with resistivity of 18.2 MΩ at 25 °C.
The vials containing cells were thawed from storage in liquid nitrogen dewars and
transferred to sterile disposable Erlenmeyer flasks (Corning). An overlay of filtered 5% CO2 in
air was supplied to the flask headspace before culture flasks were sealed and incubated on orbital
shaker platforms at 140 rpm in a 36.5 °C incubator for 3 - 5 days (Thermo Fisher). Cell culture
flasks were then grown to sufficient cell culture concentration and volumes to inoculate several
2-liter roller bottles at a working volume of 400 mL. The roller bottle cultures were pooled to
inoculate either a 7-liter scale or 15-liter scale autoclavable Applikon glass bioreactor. One
autoclavable glass bioreactor would serve as the N-1 culture to inoculate up to 4 production
bioreactors at either 15-liter scale (in Goal 1), or 7-liter scale (in Goals 2 and 3).
All production bioreactors from the same N-1 bioreactor were considered a single
“round”. Further culture designations for each individual bioreactor were given a sequential
numerical designation. For Goal 1, there were two cell lines and 4 rounds of two 15-liter
bioreactor cultures. For Goal 2, there was one cell line over three rounds of four 7-liter bioreactor
cultures. And for Goal 3, there were three cell lines with one round, with each comprising four 7liter bioreactor cultures. These data were used to demonstrate reproducible control and process
monitoring across a total of seven different cell lines.
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Daily samples from the production bioreactor cultures were taken and analyzed for
glucose concentration and viable cell concentrations by the Nova BioProfile® 400 and ViCELL™ XR, respectively. Additional analysis of daily samples is listed in Table 1. Retains for
protein concentration analysis were centrifuged at 800g for 10 minutes. The cell culture
supernatant was aliquoted into 1.5 mL cryovials and retained at -65°C or below prior to analysis
by HPLC using protein A separation.

Table 1 –

Sample Analysis and Frequency

Sample

Frequency

Preparation

Sample Volume

Storage

Daily

None

20 mL

Discard

Day 4 through
harvest

Filtered
supernatant

3 x 1.5 mL

≤ - 65°C

pH by Thermo Orion VersaStar
Glucose by Nova BioProfile® 400
Cell Count by Vi-CELL™ XR
Osmolality by freeze point
depression (Adv. Inst. 3320)
Pro A HPLC

Raman spectral pre-processing was used as described by Webster et al. (2018).
Pre-processing of the spectra used a mix of first derivative, Savitzky-Golay (SG) and Standard
Normal Variate (SNV) smoothing with trimmed spectra between wave numbers 500 and 1700
cm-1. In addition to the reference cell counts from the Vi-CELL™ XR, zero values were assigned
to media scans for VCC.
3.2.Production Culture Operations
This project was divided among 3 goals to demonstrate both the accuracy of the Raman
as well as the ability of the automation to control 2 different feeds. Each bioreactor culture that
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was operated was given a unique identifier specifying the cell line used, goal number or “round”,
and number within that criteria. As an example, the first goal using the first cell line was
specified as CL1.1_1 while the third goal used a 4th, 5th, and 6th cell line over 3 rounds for a total
of 12 bioreactors.
3.2.1. Goal 1 – Test Automation Capabilities
The first goal was to initiate automation of a glucose and nutrient feed using in-line
Raman spectroscopy to estimate the glucose concentration and VCC approximately every hour
throughout the duration of the fed-batch cultures. A total of four rounds of 2 production
bioreactors each was executed to accomplish the first goal. The first two rounds automated the
glucose feed, while the last two rounds kept the glucose automation strategy and used the Raman
VCC estimation to automate the continuous nutrient feed addition.
The first two cultures (designated CL1.1_1, and CL2.1_2) used the Raman estimation of
glucose concentration in a linear calculation to determine the glucose feed pump rate. The
process value from the iCRaman software was communicated via OPC (object linking and
embedding for process control) to BioXpert XP software provided by Applikon Biotechnology.
The proprietary text-based Bioxpert control used a simple function for changing the pump speed
of the glucose feed, based on the current glucose concentration compared to the previous glucose
concentration as well as the distance from the desired glucose concentration. An estimation from
the Raman was provided approximately every hour.
The second round of two cultures (designated CL1.1_3 CL1.1_4) also used automated
glucose feed control. However, the target or setpoint concentration for glucose control was
modified for each culture to be at the high and low acceptable limits of the process, as defined
from previous process development for the proprietary and validated process.
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In the third and fourth rounds, automation of the nutrient feed was introduced based on
the Raman estimation of VCC. The four cultures over two rounds were designated CL1.1_5,
CL1.1_6, CL2.1_7, and CL2.1_8. The same generic model for Raman VCC was used for both
cell lines to determine the feeding rate of the continuous nutrient feed rate, based on the Lonza
platform process calculation.
3.2.2. Goal 2 - Model Generation Using a DOE Approach
For the second goal, a new (third) cell line was used to culture twelve 7-liter bioreactors
to update the generic Raman model using a DOE approach. The first round was operated at
standard process parameters as the control to verify the model developed. Two additional rounds
of four bioreactors used a 3-level full factorial DOE experiment to provide a full range of
conditions across the acceptable operating range of the process as shown in Table 2. Daily offline samples were compared to in-line Raman spectroscopy from a Kaiser Optical Raman probe
to create a predictive multivariate model as described in Webster et. al. (2018).
The three factors included two amino acid containing feeds and a glucose target
concentration controlled with a glucose only feed. One feed was added continuously using the
viable cell concentration to control the rate based on a linear formula that was adjusted by 20 %
for the high or low rate. The second amino acid feed was a timed bolus feed with the total
amount of each bolus addition being adjusted by 20 % of the process target (based on bioreactor
volume).
Table 2 –
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Factors for DOE Raman Model Development

DOE
Run

Culture IDs

Nutrient Feed
Rate
(% different)

Glucose
Target

Bolus Feed
(% different)

10

CL3.1_1

0

3.0 g/L

0

9

CL3.1_2

0

3.0 g/L

0
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11

CL3.1_4

0

3.0 g/L

0

8

CL3.2_1

+20

6.0 g/L

+20

2

CL3.2_2

+20

1.0 g/L

-20

3

CL3.2_3

-20

6.0 g/L

-20

5

CL3.2_4

-20

1.0 g/L

+20

4

CL3.3_1

+20

6.0 g/L

-20

7

CL3.3_2

-20

6.0 g/L

+20

1

CL3.3_3

-20

1.0 g/L

-20

6

CL3.3_4

+20

1.0 g/L

+20

3.2.3. Goal 3 – Improve Automation Across Three New Cell Lines
The third goal used an improved connection and software solution to demonstrate
comparable process control of three additional cell lines (designated CL4, 5, and 6) using an
updated generic Raman model developed with the additional runs in goal 1.

Some

communication errors during Goal 1 were never fully understood but likely were a result of
outdated software. Upgrading the Microsoft Windows® XP PC to a Windows 7 Server in Goal 3,
along with new software on both the client side (RunTime) and server (Lucullus®) alleviated
these errors. Raman RunTime from Kaiser was used to provide the process values from the
Raman models via OPC UA (unified architecture) to Lucullus®. A built in PID controller in the
Lucullus® software was used to control pumps attached to an Applikon® bioreactor controller for
the updated glucose control. A linear formula based on the platform process was used for the
nutrient feed control based on the Raman VCC estimation.
Twelve stirred tank bioreactors were operated at 7-liter scale over 3 rounds to
demonstrate the feasibility of automated feeding strategies utilizing glucose and viable cell
concentration predictions from a Kaiser Optical Raman probe (Table 3). The software and
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hardware setup required to communicate the Raman predictions to laboratory-scale controllers
are shown in Figure 4.

Table 3 –

1

Automated and Manual Control Culture IDs for Goal 3 Automation

Automated Culture

Automated Culture

Control Culture

Control Culture

ID 1

ID 2

ID 1

ID 2

CL4.1_1

CL4.1_2

CL4.1_3

CL4.1_4

CL5.2_5

CL5.2_6

CL5.2_7

N/A1

CL6.3_9

CL6.3_10

CL6.3_11

CL6.3_12

This culture was terminated.
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Figure 4 –

Laboratory Scale Setup for Feed Automation with Raman

Lab Server with
Lucullus to control
analog output to pumps
on 2 x ADI1010

AD1010 Controller

Automated control

x2
x2
Nutrient
SF121
Feed

X2

Kaiser Rxn2
PC with Runtime,
controlling 4
Raman probes

x2
x2
Glucose
600g/L
Feed
Glucose

Manual control

X2
x2
x2
Nutrient
Feed
SF121

X2
Optical Fiber

Automated control
~Hourly feed rate adjustments
based on Raman estimation

Optical Fiber

x2
x2
Glucose
600g/L
Feed
Glucose

X2

Manual control
Feed rates adjusted daily
via offline sample

Pump tubing to add supplemental feeds
Optical fiber to transmit laser to Rxn probe heads
X2

Pump
OPC communication, data transfer
4-20 nA signal from ADI1010 to pump

Flow diagram of four bioreactors running a proprietary production process with Raman
spectroscopy to demonstrate automation. Two bioreactors utilized “Automated Control” to adjust
two feeds based on in-line Raman estimations for glucose and VCC. Two bioreactors were the
control set and had daily adjustments of the feed based on off-line measurements.
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3.3.Evaluation Criteria
3.3.1. Root Mean Squared Error Prediction (RMSEP)
To demonstrate the accuracy of the Raman model, a RMSEP estimation of the model was
used as listed in Equation 1, where YOBS is the reference value from the Nova BioProfile® or
Vi-CELL™ and YPRED is the estimation based on Raman spectra.
Equation 1 – RMSEP

3.3.2. Root Mean Squared Error Distance (RMSED)
In addition to evaluating how the models estimation for glucose compared to off-line
analysis, the distance from the glucose target was also determined using a similar equation. The
root mean square error distance (RMSED) evaluated the Raman estimation of glucose distance to
the target concentration. This demonstrated how close the control system was able to keep
glucose to the target. RMSED estimation of the control was used for each daily sample from day
5 (when glucose control was started) through day 12. As shown in Equation 2, YRAM is the
reference value from the Raman estimation of glucose, YSET is the target concentration for
glucose, and N is the total number of samples.
Equation 2 – RMSED
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4.RESULTS
4.1.Goal 1 – Test Automation Capabilities
4.1.1. Round 1 – Two 15-Liter Cultures Controlling a Glucose Feed
The monitoring and control of residual glucose concentrations using in-line Raman
spectroscopy at a target of 3 g/L were achieved for the majority of the cell culture duration
(Figure 5A & Figure 5B). It was observed at the end of culture CL1.1_1 (Figure 5A) that the
glucose concentrations taken off-line with the Nova BioProfile® 400 deviated lower than the
Raman estimations. Not shown, the lactate concentration for this culture was higher than all
other cultures due to alkali additions and pH control problems. This increased lactate
concentration that was not accounted for in the generic Raman PLS model most likely disrupted
the correlations between glucose concentration and Raman spectra. Increasing the variance
between the Raman glucose estimation and off-line values caused the glucose to drop toward 0
while the Raman estimates trended on target.
The Raman glucose estimations for the second culture in round one, CL2.1_2, trended
closely to the off-line measurements for the entire culture (Figure 5B). This demonstrated that
within the calibration model, the automated feeding strategy performed as expected. The off-line
and predicted concentrations were both maintained within the process acceptable range of 1 –
6 g/L.
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Figure 5 –

Raman Estimations and Off-Line Concentrations for Round 1 Cultures While Automating
the Glucose Feed Addition Using In-Line Raman Spectroscopy
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4.1.2. Round 2 – Automated Glucose Feed Control at the Edge of Acceptable
Limits
The second round of glucose feed control pushed the generic model to its limits by
attempting to control glucose concentration at targets of 1 and 6 g/L. At a target of 1 g/L, the
Raman prediction of glucose shows a steady reading below 2 g/L, although the off-line values
are consistently lower (Figure 6A).
The automated control of glucose at 6 g/L for CL1.2_4 is shown in Figure 6B. Although
the Raman estimation follows the off-line concentration, at 143 hours, there was a
communication failure in which the estimation was not communicating to the controller and the
pump remained on, increasing the residual glucose concentration up to a high of 11.33 g/L.
Furthermore, at the end of the culture, the estimation was consistently lower than the off-line
analysis as indicated by arrows. These data were included to create an updated model for glucose
predictions in Goal 3.
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Figure 6 –

Raman Estimations and Off-Line Concentrations for Round 2 Cultures While Automating
the Glucose Feed Addition Using In-Line Raman Spectroscopy
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4.1.3. Round 3 – Automation of Nutrient Feed and Glucose
The third round of glucose feed control for CL1.3_5 and CL1.3_6 is shown in Figure 7A &
Figure 7B. Oscillations in the residual glucose concentration can be seen due to the control
strategy only utilizing a proportional gain. No communication failures occurred, although the
oscillations did cause off-line readings to drift outside of the acceptable range of 1 – 6 g/L for
one sample on day 13 (312 hours), indicated with arrows.
The VCC estimations for each culture trended similarly to the off-line analysis through
the exponential phase of cell growth. However, the estimations based on the generic Raman
model were lower throughout the stationary phase of the culture. As this estimation was used for
the calculation of the nutrient feed addition rate, this could impact the overall nutrient feed that is
supplied to each culture during automation.
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Figure 7 –

Raman Estimations and Off-Line Concentrations for Round 3 Cultures While Automating
the Glucose Feed Addition Using In-Line Raman Spectroscopy
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The nutrient feedback control was automated based on the Raman VCC estimation for
cultures CL1.3_5 and CL1.3_6 (Figure 8A & Figure 8B). The actual flowrate of the nutrient feed
was compared to the traditional method of calculating the feed rate, using the predicted VCC
from daily off-line VCC measurements from Vi-CELL™. The Raman controlled rate follows the
target feed rate trend. However, the target rate follows a step pattern based on rate changes once
daily, as compared to hourly increases from Raman controlled rates. There is some discrepancy
in the actual VCC and Raman-estimated VCC starting around day 8 (192 hours), indicated with
arrows (Figure 8). This estimation used for the nutrient feed rate caused the actual feed rate to
differ from the target feed rate by greater than 10 % at some points in the culture. However, both
cultures utilizing automated feeding strategy in round 3 met forward processing criteria and were
harvested successfully with product concentration within historical ranges.
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4.1.4. Round 4 – Automated Nutrient Control at the Edge of Acceptable Limits
The automated glucose feed for cultures CL2.4_7 and CL2.4_8 is shown in Figure 9A &
Figure 9B. There was a communication error bringing the Raman estimations into the control
system, indicated by arrows, between 270 hours and 310 hours. The root cause of the
communication failure was not determined although changes were made as described in section
3.2.3. For CL2.4_7, the system was in between oscillations in glucose measurements and glucose
continued to drop as the pump was turned off and new readings of lower concentrations were not
communicated to the system. Once communication was restored, the system increased the pump
rate exponentially leading to a high glucose concentration of 8.10 g/L, as measured by the offline Nova BioProfile®.
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Raman Estimations and Off-Line Concentrations for Round 4 Cultures While Automating
the Glucose Feed Addition Using In-Line Raman Spectroscopy
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0
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Raman Viable Cell Concentration Estimation (106 /mL)(R)

For CL2.4_8, glucose was successfully maintained within an acceptable range with
minimal oscillation outside of the target range of +/- 1 g/L. The same communication failure
from CL2.4_7 occurred during a period where the pump was set at an optimal rate, so the
glucose did not fluctuate as it did in CL2.4_7. This shows that with a better control strategy, even
a communication failure or erroneous probe reading may be overcome for extended periods of
time.
The nutrient feed rate for Round 4 was initially to target +/- 10 % of the target value as
compared to the off-line viable cell concentration readings. Due to variation in the Raman
estimation compared to the Vi-CELL™, this was not accomplished. The difference between online and off-line VCC is shown in Figure 10A & Figure 10B. There was also a failure in
communication from the scales that were used to calculate the nutrient feed rate after 170 hrs,
due to the control system malfunction. This caused a spike in the rate of feed being added, as
calculated, based on the actual scale readings after communication was restored.
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144

Elapsed Time (h)

Nutrient Feed Rate (g/hr)(L)
Offline VCC (106 /mL)(R)

6

Nutrient Feed Rate (g/hr)(L)
Offline VCC (106 /mL)(R)

Goal 1 Summary Table
Culture

RMSED Glucose

0

0

96

-48

Elapsed Time (h)
Target Nutrient Feed Rate (g/hr)(L),
Raman VCC Estimation (106 /mL)(R),

Within 1 g/L

RMSEP VCC

Feed error %

Acceptable?
CL1.1_1

1.28

No

5.80

6%

CL2.1_2

0.68

Yes

3.90

15%

CL1.2_3

1.04

No

7.49

10%

CL1.2_4

2.16

No

15.81

5%

CL1.3_5

1.40

No

8.10

15%

CL1.3_6

1.36

No

14.53

11%

CL2.4_7

2.28

No

5.57

41%

CL2.4_8

1.16

No

9.25

39%

In summary, for Goal 1 (Table 4), the control, as measured by RMSED, was not within
the target range of 1 g/L glucose concentration. The oscillation around the setpoint and
communication issues with the glucose control were not sufficient for the tight expectation of
therapeutic protein production. Additionally, the RMSEP for the VCC predictions was also
higher than anticipated. Failures of process control caused culture conditions to arise that were
not previously developed in the Raman model. To overcome these challenges, improved model
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development procedures and new software and communications solutions were introduced for
the second and third goal of the present thesis.
Additionally, the increased updates for the feed rates with automation had an unintended
increase in feed. This is most obvious with CL2.1_2 (Figure 5), which had the lowest RMSEP
but barely acceptable feed rate control. Conversely, the highest RMSEP in CL1.2_4 (Figure 6)
had the lowest feed error because it was consistently underestimating the viable cell
concentration. Communication errors during round 4 (Figure 9) also increased error, although the
in-line measurements were in line with the other cultures and likely would have been acceptable
without the software failure.
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4.2.Goal 2 – DOE Model Development
Based on the poor performance of the VCC model while changing the feeding parameters,
a more robust model development procedure was established by using a DOE approach. The
nutrient feed is heavily correlated with the VCC. As the VCC is used to calculate how much
nutrient feed is added, this was expected. By automating the feed based on the Raman estimation
of VCC, small errors in the estimation changed the feed rate, thus compounding the error later
and potentially breaking some correlation between the feed and VCC. This was most apparent at
the end of the culture in the decline phase, as shown in Figure 11.
Figure 11 –

Nutrient Feed and VCC Correlation During the Generic Model Development
B) Generic Model - Full Culture Duration

A) Generic Model - Exponential Phase

R2 = 0.69

Amount of Nutrient Feed Added (g)

Amount of Nutrient Feed Added (g)

R2 = 0.85

Viable Cell Concentration

Viable Cell Concentration

A – before day 10, a strong linear correlation (R2 = 0.85) between the VCC and nutrient feed is shown
while the culture is still growing or stationary.
B – during the death phase of the culture growth curve, the amount of nutrient feed is still increasing
while the VCC declines, reducing correlation slightly (R2 = 0.69). This shift-up and to the left, as shown
by the two groups indicated with ovals, correspond to the different cell lines used for the first goal’s
control.

4.2.1. Factors for the Design of Experiments
Because the nutrient feed was added based on the VCC, different feed rates were
hypothesized to reduce the correlation between various amino acids that are Raman active and
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VCC. By adjusting the target feed rate to a high, middle, and low rate, the amount of feed was
varied between different conditions. The purpose of this approach was to improve the VCC
estimation, as well as demonstrate a cost-effective model development procedure for multiple
cell lines and media formulations, which may not be represented in the generic model previously
established.
The overall feed amounts between high, control, and low feed rate conditions, as laid out
in the designed experiment, are shown in Figure 12. However, a difference among conditions
was only clearly delineated after day 10 (240 hours), when higher feed rates could overcome
smaller variations in cell counts or pump and scale control variations.
Figure 12 –

Mass of Nutrient Feed Added to Cultures of Cell Line CL3 During DOE Model Creation
Using In-Line Raman Spectroscopy

Mass of Nutrient Feed Added per Bioreactor Volume (g/L BR)
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The profiles for VCC are shown in Figure 13. Most cultures followed similar trends with
one exception in CL3.3_2. The VCC profiles between conditions demonstrate variability only
about 72 hours after culture inoculation.
Figure 13 –

Nutrient Feed and VCC Correlation Between Cultures in a DOE
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The correlation between the amount of feed added and VCC with the DOE approach for
the full culture duration (R2 of 0.37 in Figure 14B) was reduced compared to generic model
generation (R2 of 0.69 in Figure 11B). The initial correlation during the culture’s exponential
phase (Figure 14A) was comparable to previous experiments (Figure 11A), as the feed rates were
maintained within the process acceptable ranges to avoid risk of culture failure.
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Figure 14 –

Nutrient Feed and VCC Correlation Between Cultures in a DOE

A) DOE Model - Exponential Phase

B) DOE Model - Full Culture Duration

R2 = 0.83

Amount of Nutrient Feed Added (g)

Amount of Nutrient Feed Added (g)

R2 = 0.37

Viable Cell Concentration

Viable Cell Concentration

A – before day 10, a strong linear correlation (R2 = 0.83) between the VCC and nutrient feed is shown
while the culture is still growing or stationary.
B – during the death phase of the culture growth curve, the amount of nutrient feed is more influenced by
the change in rates as part of the DOE, reducing correlation further (R2 = 0.37). This shift-up and to the
left, as shown by the two groups indicated with ovals, correspond to the different nutrient feed rates used
as part of the DOE.

The glucose concentration for eight experimental cultures conforms to the DOE design
conditions (Figure 15). Some overlap between conditions occurred due to equipment and
operations errors, while using once daily measurements to control the glucose concentration.
This was most prevalent on day 8 (192 hours) of the control cultures, when the off-line values
used for glucose concentration were taken from the generic Raman model prediction due to a
failure with the Nova, which did not impact the study or DOE design. Additionally, the initial
glucose concentrations were not perturbed by adjusting the concentration of glucose in the initial
media. This resulted in a slow decline to the target control setpoint of 3 g/L after approximately
96 hours when the culture had consumed the excess glucose concentration. The glucose
concentration in the basal media prior to inoculation could be experimentally deviated in order to
further optimize the glucose model, as previously done for the generic model (Webster, et al.,
2018). However, the cost for custom media may be prohibitive and there may be limited benefits
prior to initiating control of glucose at a lower target concentration.
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Figure 15 –

Glucose Concentration in Cultures of Cell Line CL3 During DOE Model Creation Using
In-Line Raman Spectroscopy
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4.2.2. Comparison of DOE and Generic Raman Model Development
The developed DOE models for glucose and VCC showed improvements in estimations,
in terms of percent error between the RMSEP and concentration ranges (

Table 5). This reduction was achieved with 43% less observations, meaning fewer
cultures and faster turnaround for the Raman model development.
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Table 5 –

Goal 2 Summary Table

Culture

Generic VCC
Model

DOE VCC

Reduction

Generic
Glucose
Model

DOE
Glucose

Reduction

Observations

430

243

43 %

430

247

43 %

RMSEP for G2.1_1

2.73

1.99

27 %

0.66

0.39

41 %

RMSEP for G2.1_2

3.08

2.64

14 %

0.40

0.37

8%

RMSEP for G2.1_4

6.30

1.88

70 %

0.77

0.57

26 %

RMSED was not measured, as automation of the glucose feed did not occur

4.3.Goal 3 – Improve Automation Across Three New Cell Lines
4.3.1. Controlled Automation R1 - Cell Line CL4
A comparison of VCC and glucose concentrations between cultures for the CL4 cell line
is shown (Figure 16). In culture CL4.1_2 (Figure 16B arrow), there is a slight shift in Raman
estimation of glucose concentration below the target of 3 g/L to above 3 g/L after day 9. This was
caused by manual adjustments at this time to the PID parameters for controlling glucose,
temporarily increasing the glucose feed rate. This one-time manual adjustment to reduce error
between the proportional pump output demonstrated the potential need for an integral term or
other improvements to control strategies. However, both automated cultures, overall, showed
tighter control of glucose around the setpoint than the manually controlled cultures CL4.1_3, and
CL4.1_4 (Figure 16C and Figure 16D). This was also supported by the RMSED from glucose
setpoint (Table 6).
Due to operational and manual errors, culture CL4.1_4 (Figure 16D) suffered fluctuations
in glucose concentration not related to typical off-line control. Without the errors, it is expected
that the control culture would have had improved control of glucose around the setpoint. An
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off-line glucose concentration of 0.29 g/L on day 10 was outside the acceptable range. This outof-specification result could lead to increased cost during commercial manufacturing or even a
loss of a batch. Furthermore, this error was compounded in the next daily sample leading to an
additional excursion outside of the process range on day 12, with a glucose concentration of 0.24
g/L.
The Raman estimations for VCC for all cultures showed a good correlation to off-line
VCC measurements up until day 8, approximately 190 hours. At the end of the culture, the
Raman estimations for VCC were consistently higher than off-line measurements. The increased
frequency of nutrient feed adjustments along with higher Raman estimation resulted in a total
increase of nutrient feed for the automated cultures, CL4.1_1 and CL4.1_2. This difference in
nutrient feed between automatic and manually controlled cultures may have caused lower VCC
at harvest for the automated cultures (data not shown).
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Figure 16 –

Comparison of the Control Achieved with Different Feeding Strategies Using Cell Line
CL4
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4.3.2. Controlled Automation R2 - Cell Line CL5
A comparison between four different cultures of the CL5 cell line is depicted in Figure 17.
The accuracy of the glucose model at the end of the culture started to decline, when the off-line
glucose concentration measurement was consistently lower than the Raman estimation. Because
of this, there was limited benefit in the automated control compared to manual control (Table 6).
Further model development or specific cell line models may improve the ability to more
accurately measure and control glucose concentration for this cell line using Raman spectroscopy.
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Figure 17 –

Comparison of the Control Achieved with Different Feeding Strategies Using the Cell
Line CL5
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4.3.3. Controlled Automation R3 - Cell Line CL6
Cell line 6 automated cultures (Figure 18A & Figure 18B) are compared to manually
controlled cultures (Figure 18C & Figure 18D). A manual error impacted the automated culture
CL6.3_10 (Figure 18B). A drop below the glucose setpoint occurred during the start of glucose
control, when the pump for the glucose feed was set in the wrong direction. This was detected
prior to an excursion outside of the acceptable range, with an off-line glucose concentration of
1.58 g/L at the lowest point prior to correcting the pump direction. The tubing from the glucose
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feed to the bioreactor was re-primed and the pump direction was corrected. The Raman
estimations show a steady recovery back to setpoint relying on the automated control.
The

manually

controlled

culture

CL6.3_11

(Figure 18C)

maintained

glucose

concentration close to setpoint similar to the automated cultures. This demonstrates that using a
proprietary glucose calculator to control glucose concentration based on daily off-line samples
can be an effective strategy. However, unknown process variability potentially present in
CL6.3_12 (Figure 18D) shows this is not as robust as an automated strategy with hourly
monitoring.

Figure 18 –

Comparison of the Control Achieved with Different Feeding Strategies Using the Cell Line
CL6
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4.3.4. Quantitative Analysis of Automation
The overall differences between the manual control and automated control cultures are
summarized in Table 6 for the glucose and nutrient feed. The root mean squared distance
(RMSED) from glucose setpoint is analyzed for all cultures from day 5 through 12 for each daily
sample. The automatically controlled cultures had a 36 % lower distance to setpoint compared to
the manually controlled cultures, when calculating the difference between the daily off-line
glucose concentration and the target of 3 g/L.
Table 6 –

Goal 3 Summary Table

Unique
Culture ID

1

Type of
Control

RMSED From
Glucose Setpoint1

Within 1 g/L

RMSEP
VCC

Feed within 15%
of off-line
calculated rate

CL4.1_1

Auto

0.4

Yes

1.96

No

CL4.1_2

Auto

0.4

Yes

3.41

No

CL4.1_3

Manual

1.3

No

2.51

N/A

CL4.1_4

Manual

1.7

No

2.83

N/A

CL5.2_5

Auto

1.2

No

2.82

Yes

CL5.2_6

Auto

0.8

Yes

2.15

Yes

CL5.2_7

Manual

1.1

No

2.43

N/A

CL6.3_9

Auto

0.4

Yes

2.96

No

CL6.3_10

Auto

0.8

Yes

2.86

Yes

CL6.3_11

Manual

0.4

Yes

11.42

N/A

CL6.3_12

Manual

0.9

Yes

2.59

N/A

Measured from day 5 onward to ensure control was enabled

The nutrient feed target flowrate at each daily sample based on the off-line VCC was
compared to the actual flowrate for the automated cultures. The process has been demonstrated
to be robust within a 15% difference of the nutrient feed flowrate. Only half of the automated
cultures in this evaluation were within this tested range. The cultures with higher amounts of
feed did have tendency to exhibit lower VCC and viability at harvest. However, product
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concentration and product quality attributes were comparable to manual control cultures,
demonstrating process reproducibility (data not shown). Also because of the nature of automated
feeding updating more frequently, even low error of prediction led to over feeding if the Raman
was overestimating the off-line cell concentration measurement.
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5.DISCUSSION
5.1.Goal 1 - Test Automation Capabilities
The first attempt at automation of the glucose and nutrient feed demonstrated the
potential of in-line Raman spectroscopy for real-time control of fed-batch mammalian cell
culture. However, as measured by RMSED, this early model to automate the glucose and nutrient
feed was not an improvement over current daily monitoring and control for commercial
processes. The control of the glucose feed did not lead to maintaining the glucose concentration
within 1 g/L of the setpoint glucose concentration. The oscillation around the setpoint and
communication issues exacerbated minor error with Raman estimations compared to off-line
methods. Additionally, operational errors in some cultures exposed further limitations like
potential interference with increased lactate concentrations, contrary to previously demonstrated
closed loop lactate control (Matthews, et al., 2016).
The deviation between Raman estimations and off-line measurements for glucose at the
end of cultures CL1.2_3 and CL1.2_4 demonstrated a need to increase the range within the
model calibration dataset. PLS regression used to create the Raman model cannot extrapolate. As
the off-line glucose concentration dropped below 1 g/L, or climbed above 6 g/L, the model
estimations fail to adequately follow because the model had not seen these concentrations
previously (Milligan, et al., 2014).
An equipment failure caused an artificial drop of the pH measured by the system. The
controller responded to this with an increase in alkali to cultures CL1.1_1 and CL1.2_3. This
impacted numerous parameters in the culture performance from cell growth to metabolism.
Higher concentrations of lactate in these cultures could have increased peaks in Raman spectra
that were also incorporated into the PLS model for glucose. This likely resulted in the Raman
model estimating a higher concentration of glucose in the presence of higher lactate
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concentrations that were not incorporated during the original generic model development.
Including this data in future studies adds variability that increases the specificity of the model to
measure glucose and reduce collinearity with other components in the cell culture. Other
methods of chemometric models or reducing wavenumber regions used could also be explored
(Rafferty, Johnson, et al., 2020).
A failure of the Raman probe during the fourth round of Goal 1 may have also impacted
the VCC estimations. As shown in Figure 10, the VCC estimation for CL2.4_8 dropped below 0
cells/mL around 290 hours. Because a negative value is not possible, the software used a value of
“0” for the VCC estimates in order to calculate the nutrient feed rate in the late stage of this
culture. The algorithm used for the calculation of the feed rate was designed to provide a
minimum feed rate at this stage in the culture, which allowed comparable feed rates compared to
targets after day 11, approximately 275 hours. Although this was not a success of the automation,
the method of feed rate calculation allowed for comparable control, despite shortcomings in the
Raman VCC estimations in this early model. The cause of this probe failure could not be
determined. However, backup probes would allow redundancy and determination of a difference
in probe performance so a failure could be mitigated during operation. In a clinical or
commercial manufacturing facility, multiple systems would also be recommended (Moore, et al.,
2019).
5.2.Goal 2 - Model Generation Using a Design of Experiments (DOE) Approach
The generic model demonstrated an ability to estimate and control glucose in a limited
range. However, to improve VCC and glucose estimations, process specific models may be
required. The DOE model demonstrated a reliable and cost-effective method of model
development for improved glucose and VCC monitoring. This allows novel processes or cell
lines to utilize Raman in a well-controlled process with minimal laboratory scale work, or by
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utilizing already required process characterization studies when scaling up for commercial
manufacturing (Whelan, et al., 2012).
The DOE approach showed reduced correlation between process attributes like VCC and
feeds. This was a critical achievement to introduce robust control for current Good
Manufacturing Processes. Also, each cell line and product may require specific model
development as part of the discovery process. By reducing the number of bioreactor runs
required to implement PAT into a Biologics License Applications (BLA) regulated under Code of
Federal Regulations (CFR) Title 21 Parts 600 – 680, in this instance Raman, this approach can
save time and money. This ultimately also leads to improved automation and control for clinical
and commercial manufacturing of bulk drug substances. However, multiple correlating factors
may impact VCC and complicate the model development process. Prior process understanding of
how to achieve a high and low VCC to increase model variability may not be as simple as
adjusting one or two parameters.
There was a probe that could not be used during this experiment. In this case the failure
was detected during bioreactor set up and having a spare probe would have allowed continued
use of Raman in this culture. Additionally, this was the same probe that had provided poor VCC
estimations in culture CL2.4_8 (likely an explanation for the obtained value being below 0
cells/mL; see section 5.1. Goal 1). Increased understanding of failure modes and appropriate
actions to remedy in a timely manner are critical to utilize this technology. Also, buying
additional equipment to provide redundancy may be cost prohibitive in early development but
required during clinical and commercial manufacturing of therapeutics.
5.3.Goal 3 - Improve Automation Across Three New Cell Lines
Improving the systems used in Goal 1 along with the model improvement of Goal 2
provided a strong demonstration of the automation potential using Raman spectroscopy in Goal 3.
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There were some operation errors with the glucose feed rate including initially pumping
the glucose feed in the wrong direction. While manual errors such as what occurred at lab scale
are not frequent in GMP manufacturing, the automated method and hourly measurements of
glucose from Raman spectroscopy demonstrate an ability to not only recognize an error, but also
allow correction prior to the next sampling point.
The Raman VCC estimation was comparable to the off-line VCC. However, a manual
error in delaying an adjustment to the feed rate calculation after a target integral of viable cell
curve (IVCC) was reached (Renard, et al., 1988) contributed to an overall increased feed rate of
12 % compared to using daily off-line VCC measurements. With better automation to provide
automated IVCC calculations and shift timers, the manual adjustment would not have been
required.
The Raman VCC estimations for culture CL6.3_11 (Figure 18C) are consistently
different from the off-line value. Because this was a manually controlled culture, this did not
have an impact on the culture or the current study. The cause of this higher estimation could not
be determined; backup probes for commercial manufacturing would allow determination of a
difference between probes if this were related to a probe failure. Another concern for Raman is a
potential for fluorescent interference (Aubin, 1979; Matthews, et al., 2018), which may require
different equipment or process optimization. However, interference in the model would likely be
caused by cell line or media and feed composition. In the current study, fluorescent interference
was not seen, or was well controlled for, across all cell lines and probes using identical media
and feeds.
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5.4.Further Applications
The ability to estimate glucose and VCC using a generic Raman model across six
CHOK1SV GS-KO® and GS-CHO cell lines was discussed. The use of Raman spectroscopy for
automated glucose control was successfully demonstrated for several different cell lines in
Lonza’s GS fed-batch cell culture process. Automated nutrient feed control for the six cell lines
was shown to produce comparable process attributes. Extending this to more process attributes,
like pH, may also extend the usefulness of this technology (Rafferty, et al., 2020).
The metabolite and productivity profiles of all cultures were comparable between the
respective cell lines operated in each round. The automated glucose control demonstrated
reduced oscillation around the set point concentration compared to manual daily glucose feed
adjustments. For one cell line, VCC at harvest may have been affected by an increased rate of
nutrient feed as a result of automation. However, improved model accuracy using a cell line
specific DOE or control based on amino acid concentrations could improve process
reproducibility (Tulsyan, et al., 2019).
Future work may show that controlling feeds containing amino acids can be controlled
using estimations of an amino acid concentration from Raman instead of viable cell
concentration (Webster, et al., 2020). This can provide a more transferrable model as was seen
with the robustness of glucose estimation between the generic and DOE modeling approaches.
Additionally, for process control, the VCC could be a lagging indicator of a nutrient depletion. A
rate limiting amino acid or other metabolite likely is depleted before the cells begin to decline.
This could also show benefits in reducing waste or cost of goods if excess nutrients are being
supplied because of process or raw material variability (Huang, et al., 2010).
The reduction of waste or concentrations of amino acids could also assist in limiting
background fluorescence. As shown in some failed cultures, excess feed additions could have
50

MAMMALIAN CELL CULTURE CONTROL WITH RAMAN SPECTROSCOPY
contributed to poor estimations in VCC. By limiting the aromatic amino acids that are known to
cause autofluorescence in the 785nm wavelength region, future issues, or different equipment,
could be avoided (Matthews, et al., 2018).
The platform processes used in the present thesis research project were optimized with
thoroughly tested cell lines. The improved automated control of three cell lines was comparable
to traditional daily monitoring and manual control cultures. The automation achieved has a
strong potential to improve the safety and cost of manufacturing therapeutic proteins in the future.
More complex changes in process development and control could further reduce waste
accumulation and improve titer concentrations, which would be critical to the long-term success
and implementation of Raman spectroscopy throughout the industry.
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